AT17300U3 - Solid oral pharmaceutical composition - Google Patents

Solid oral pharmaceutical composition Download PDF

Info

Publication number
AT17300U3
AT17300U3 ATGM113/2020U AT1132020U AT17300U3 AT 17300 U3 AT17300 U3 AT 17300U3 AT 1132020 U AT1132020 U AT 1132020U AT 17300 U3 AT17300 U3 AT 17300U3
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
solid oral
oral pharmaceutical
disintegrant
lubricant
Prior art date
Application number
ATGM113/2020U
Other languages
German (de)
Other versions
AT17300U2 (en
Original Assignee
G L Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by G L Pharma Gmbh filed Critical G L Pharma Gmbh
Priority to ATGM113/2020U priority Critical patent/AT17300U3/en
Publication of AT17300U2 publication Critical patent/AT17300U2/en
Publication of AT17300U3 publication Critical patent/AT17300U3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Abstract

Feste orale pharmazeutische Zusammensetzung enthaltend Lurasidon oder ein pharmazeutisch annehmbares Salz davon, Stärke, Zuckeralkohol, ein Sprengmittel, und ein Schmiermittel.Solid oral pharmaceutical composition containing lurasidone or a pharmaceutically acceptable salt thereof, starch, sugar alcohol, a disintegrant, and a lubricant.

ATGM113/2020U 2020-12-03 2020-12-03 Solid oral pharmaceutical composition AT17300U3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ATGM113/2020U AT17300U3 (en) 2020-12-03 2020-12-03 Solid oral pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ATGM113/2020U AT17300U3 (en) 2020-12-03 2020-12-03 Solid oral pharmaceutical composition

Publications (2)

Publication Number Publication Date
AT17300U2 AT17300U2 (en) 2021-12-15
AT17300U3 true AT17300U3 (en) 2022-02-15

Family

ID=78951103

Family Applications (1)

Application Number Title Priority Date Filing Date
ATGM113/2020U AT17300U3 (en) 2020-12-03 2020-12-03 Solid oral pharmaceutical composition

Country Status (1)

Country Link
AT (1) AT17300U3 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1884242A1 (en) * 2005-05-26 2008-02-06 Dainippon Sumitomo Pharma Co., Ltd. Pharmaceutical composition
EP1974724A2 (en) * 2000-09-22 2008-10-01 Dainippon Sumitomo Pharma Co., Ltd. Oral preparations with good disintegration
CN103054824A (en) * 2012-12-21 2013-04-24 北京万全德众医药生物技术有限公司 Lurasidone hydrochloride orally-disintegrating tablet preparation and preparation method thereof
WO2016139683A2 (en) * 2015-03-05 2016-09-09 Jubilant Generics Limited Pharmaceutical compositions of lurasidone and process for preparing the same
CN106074414A (en) * 2012-07-12 2016-11-09 成都康弘药业集团股份有限公司 A kind of oral cavity disintegration tablet containing Lurasidone and preparation method thereof
CN106539768A (en) * 2015-09-18 2017-03-29 成都康弘药业集团股份有限公司 A kind of Lurasidone HCl oral cavity disintegration tablet and preparation method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1974724A2 (en) * 2000-09-22 2008-10-01 Dainippon Sumitomo Pharma Co., Ltd. Oral preparations with good disintegration
EP1884242A1 (en) * 2005-05-26 2008-02-06 Dainippon Sumitomo Pharma Co., Ltd. Pharmaceutical composition
CN106074414A (en) * 2012-07-12 2016-11-09 成都康弘药业集团股份有限公司 A kind of oral cavity disintegration tablet containing Lurasidone and preparation method thereof
CN103054824A (en) * 2012-12-21 2013-04-24 北京万全德众医药生物技术有限公司 Lurasidone hydrochloride orally-disintegrating tablet preparation and preparation method thereof
WO2016139683A2 (en) * 2015-03-05 2016-09-09 Jubilant Generics Limited Pharmaceutical compositions of lurasidone and process for preparing the same
CN106539768A (en) * 2015-09-18 2017-03-29 成都康弘药业集团股份有限公司 A kind of Lurasidone HCl oral cavity disintegration tablet and preparation method thereof

Also Published As

Publication number Publication date
AT17300U2 (en) 2021-12-15

Similar Documents

Publication Publication Date Title
ATE474561T1 (en) ORODISPERSIBLE PHARMACEUTICAL COMPOSITION FOR ORAL, OROMUCOSAL OR SUBLINGUAL ADMINISTRATION OF AGOMELATIN
WO2019060322A3 (en) High dosage valbenazine formulation and compositions, methods, and kits related thereto
CY1111470T1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLYVERSERIN POLYMORPH A
NO20075323L (en) Nutritional preparation for HIV patients
RS53570B1 (en) Dpp iv inhibitor formulations
EA200901393A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING GESTAGENES AND / OR ESTROGENS AND 5 METHYL- (6S) -TETRAHYDROPHOLATE
HUP0303325A2 (en) Pharmaceutical salts and pharmaceutical compositions containing them
BRPI0612188B8 (en) pharmaceutical preparation for oral application, method for producing an oral pharmaceutical preparation, tablet preparation for oral application, method for producing a tablet preparation
JP2010047612A5 (en)
PE20110121A1 (en) PHARMACEUTICAL COMPOSITIONS OF ALISKIREN
NO20080164L (en) N- (pyridin-2-yl) -sulfonamidderivater
NO20082047L (en) Slow release composition, process for its preparation and use thereof
DK1755578T3 (en) Chewable, absorbable and swallowable tablet containing a calcium-containing compound as active ingredient
BR0210139A (en) Pharmaceutical Compositions
DE602004011398D1 (en) DIRECT COMPRESSIBLE PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF CCI-779
TR200201174T2 (en) Pharmaceutical compositions containing fluoroquinolone antibiotic medicine and xanthan gum.
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
EP3866767A4 (en) Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or its salt
CY1109865T1 (en) Valsartan Compositions
AT17300U3 (en) Solid oral pharmaceutical composition
NO20062668L (en) Oral formulations of deoxypeganine and applications thereof
ATE460934T1 (en) PHARMACEUTICAL PREPARATIONS OF CIPROFLOXACIN
ATE465741T1 (en) 9A-CARBAMOYL-Y-AMINOPROPYL AND 9A-THIOCARBAMOYL-Y-AMINOPROPYL AZALIDES WITH ANTIMALARIA ACTIVITY
CL2023000764A1 (en) Multiparticulate dosage forms comprising deutetrabenazine
JP2019522030A5 (en)